Skip to main content
Erschienen in: Clinical and Experimental Nephrology 2/2011

01.04.2011 | Original Article

A simple model for predicting incidence of chronic kidney disease in HIV-infected patients

verfasst von: Minoru Ando, Naoki Yanagisawa, Atsushi Ajisawa, Ken Tsuchiya, Kosaku Nitta

Erschienen in: Clinical and Experimental Nephrology | Ausgabe 2/2011

Einloggen, um Zugang zu erhalten

Abstract

Background

Human immunodeficiency virus (HIV)-infected individuals have concurrent risk factors for chronic kidney disease (CKD), but there are no prediction models to quantify the effect of multiple factors on the development of incident CKD.

Methods

A 1-year prognostic model was developed using prospective data between January 2008 and March 2009, from a derivation cohort of 623 patients with an estimated glomerular filtration rate (eGFR) exceeding 60 ml/min/1.73 m2 at baseline. Incident CKD was defined as both an eGFR falling below 60 ml/min/1.73 m2 and a decrease in eGFR of at least 25% during the period. Continuous variables were divided into categories using the mean value of the whole cohort. Multivariate logistic regression was used to determine baseline categories associated with incident CKD. The model was tested with prospective data between April 2009 and March 2010, from a validation cohort of 534 patients exceeding 60 ml/min/1.73 m2 at baseline, consisting of part of the derivation cohort and newly enrolled patients. The discriminative ability was evaluated using the area under the receiver operating characteristic (AROC) curve.

Results

Eighteen subjects developed incident CKD (2.9%). In a multivariate logistic regression analysis of the derivation cohort, 5 variables (age, CD4 cell count, diabetes, proteinuria, and eGFR at baseline) were independently associated with the incidence of CKD. The AROC curve was 0.841 (95% CI 0.799–0.894) in the validation cohort.

Conclusion

This prediction model may be a useful tool for identifying HIV-infected individuals with a high likelihood of new-onset CKD.
Literatur
1.
Zurück zum Zitat Eggers PW, Kimmel PL. Is there an epidemic of HIV infection in the US ESRD program? J Am Soc Nephrol. 2004;15:2477–85.PubMedCrossRef Eggers PW, Kimmel PL. Is there an epidemic of HIV infection in the US ESRD program? J Am Soc Nephrol. 2004;15:2477–85.PubMedCrossRef
2.
Zurück zum Zitat Schwartz EJ, Szczech LA, Ross MJ, Klotman ME, Winston JA, Klotman PE. Highly active antiretroviral therapy and the epidemic of HIV+ end-stage renal disease. J Am Soc Nephrol. 2005;16:2412–20.PubMedCrossRef Schwartz EJ, Szczech LA, Ross MJ, Klotman ME, Winston JA, Klotman PE. Highly active antiretroviral therapy and the epidemic of HIV+ end-stage renal disease. J Am Soc Nephrol. 2005;16:2412–20.PubMedCrossRef
3.
Zurück zum Zitat Lucas GM, Mehta SH, Atta MG, Kirk GD, Galai N, Vlahov D, et al. End-stage renal disease and chronic kidney disease in a cohort of African-American HIV-infected and at-risk HIV-seronegative participants followed between 1988 and 2004. AIDS. 2007;21:2435–43.PubMedCrossRef Lucas GM, Mehta SH, Atta MG, Kirk GD, Galai N, Vlahov D, et al. End-stage renal disease and chronic kidney disease in a cohort of African-American HIV-infected and at-risk HIV-seronegative participants followed between 1988 and 2004. AIDS. 2007;21:2435–43.PubMedCrossRef
4.
Zurück zum Zitat Winston J, Deray G, Hawkins T, Szczech L, Wyatt C, Young B. Kidney disease in patients with HIV infection and AIDS. Clin Infect Dis. 2008;47:1449–57.PubMedCrossRef Winston J, Deray G, Hawkins T, Szczech L, Wyatt C, Young B. Kidney disease in patients with HIV infection and AIDS. Clin Infect Dis. 2008;47:1449–57.PubMedCrossRef
5.
Zurück zum Zitat Post FA, Holt SG. Recent developments in HIV and the kidney. Curr Opin Infect Dis. 2009;22:43–8.PubMedCrossRef Post FA, Holt SG. Recent developments in HIV and the kidney. Curr Opin Infect Dis. 2009;22:43–8.PubMedCrossRef
6.
Zurück zum Zitat Kalaitzidis RG, Bakiris GL. Prehypertension: is it relevant for nephrologists? Kidney Int. 2010;77(3):194–200.PubMedCrossRef Kalaitzidis RG, Bakiris GL. Prehypertension: is it relevant for nephrologists? Kidney Int. 2010;77(3):194–200.PubMedCrossRef
7.
Zurück zum Zitat Jafar TH, Schmid CH, Landa M, Giatras I, Toto R, Remuzzi G, et al. Angiotensin-converting-enzyme inhibitors and progression of nondiabetic renal disease: a meta-analysis of patient-level data. Ann Intern Med. 2001;135:73–87.PubMed Jafar TH, Schmid CH, Landa M, Giatras I, Toto R, Remuzzi G, et al. Angiotensin-converting-enzyme inhibitors and progression of nondiabetic renal disease: a meta-analysis of patient-level data. Ann Intern Med. 2001;135:73–87.PubMed
8.
Zurück zum Zitat Mogensen CE. Twelve shifting paradigms in diabetic renal disease and hypertension. Diabetes Res Clin Pract. 2008;82(Suppl 1):S2–9.PubMedCrossRef Mogensen CE. Twelve shifting paradigms in diabetic renal disease and hypertension. Diabetes Res Clin Pract. 2008;82(Suppl 1):S2–9.PubMedCrossRef
9.
Zurück zum Zitat Kasiske BL, Lakatuab JD, Ma JZ, Louise TA. A meta-analysis of the effects of dietary protein restriction on the rate of decline in renal function. Am J Kidney Dis. 1998;31:954–61.PubMedCrossRef Kasiske BL, Lakatuab JD, Ma JZ, Louise TA. A meta-analysis of the effects of dietary protein restriction on the rate of decline in renal function. Am J Kidney Dis. 1998;31:954–61.PubMedCrossRef
10.
Zurück zum Zitat Gansevoort RT, Bakker SJL, de Jong PE. Early detection of progressive chronic kidney disease: is it feasible? J Am Soc Nephrol. 2006;17:1218–20.PubMedCrossRef Gansevoort RT, Bakker SJL, de Jong PE. Early detection of progressive chronic kidney disease: is it feasible? J Am Soc Nephrol. 2006;17:1218–20.PubMedCrossRef
11.
Zurück zum Zitat Taai MW, Brenner BM. Predicting initiation and progression of chronic kidney disease: developing renal risk scores. Kidney Int. 2006;70:1694–705.CrossRef Taai MW, Brenner BM. Predicting initiation and progression of chronic kidney disease: developing renal risk scores. Kidney Int. 2006;70:1694–705.CrossRef
12.
Zurück zum Zitat Mocroft A, Kirk O, Gatell J, Reiss P, Gargalianos P, Zilmer K, et al. Chronic renal failure among HIV-1-infected patients. AIDS. 2007;21:1119–27.PubMedCrossRef Mocroft A, Kirk O, Gatell J, Reiss P, Gargalianos P, Zilmer K, et al. Chronic renal failure among HIV-1-infected patients. AIDS. 2007;21:1119–27.PubMedCrossRef
13.
Zurück zum Zitat Wyatt CM, Winston JA, Malvestutto CD, Fishbein DA, Barash I, Cohen AJ, et al. Chronic kidney disease in HIV infection: an urban epidemic. AIDS. 2007;21:2101–3.PubMedCrossRef Wyatt CM, Winston JA, Malvestutto CD, Fishbein DA, Barash I, Cohen AJ, et al. Chronic kidney disease in HIV infection: an urban epidemic. AIDS. 2007;21:2101–3.PubMedCrossRef
14.
Zurück zum Zitat Cheung CY, Wong KM, Lee MP, Liu YL, Kwok H, Chung R, et al. Prevalence of chronic kidney disease in Chinese HIV-infected patients. Nephrol Dial Transplant. 2007;22:3186–90.PubMedCrossRef Cheung CY, Wong KM, Lee MP, Liu YL, Kwok H, Chung R, et al. Prevalence of chronic kidney disease in Chinese HIV-infected patients. Nephrol Dial Transplant. 2007;22:3186–90.PubMedCrossRef
15.
Zurück zum Zitat Fernando SK, Finkelstein FO, Moore BA, Weissman S. Prevalence of chronic kidney disease in an urban HIV infected population. Am J Med Sci. 2008;335:89–94.PubMedCrossRef Fernando SK, Finkelstein FO, Moore BA, Weissman S. Prevalence of chronic kidney disease in an urban HIV infected population. Am J Med Sci. 2008;335:89–94.PubMedCrossRef
16.
Zurück zum Zitat Odden MC, Scherzer R, Bacchetti P, Szczech LA, Sidney S, Grunfeld C, Shlipak MG. Cystatin C level as a marker of kidney function in human immunodeficiency virus infection: the FRAM Study. Arch Intern Med. 2007;167:2213–9.PubMedCrossRef Odden MC, Scherzer R, Bacchetti P, Szczech LA, Sidney S, Grunfeld C, Shlipak MG. Cystatin C level as a marker of kidney function in human immunodeficiency virus infection: the FRAM Study. Arch Intern Med. 2007;167:2213–9.PubMedCrossRef
17.
Zurück zum Zitat Daugas E, Rougier JP, Hill G. HAART-related nephropathies in HIV-infected patients. Kidney Int. 2005;67:393–403.PubMedCrossRef Daugas E, Rougier JP, Hill G. HAART-related nephropathies in HIV-infected patients. Kidney Int. 2005;67:393–403.PubMedCrossRef
18.
Zurück zum Zitat Izzedine H, Harris M, Perazella M. The nephrotoxic effect of HAART. Nat Rev Nephrol. 2009;5:563–73.PubMedCrossRef Izzedine H, Harris M, Perazella M. The nephrotoxic effect of HAART. Nat Rev Nephrol. 2009;5:563–73.PubMedCrossRef
19.
Zurück zum Zitat Côté HCF, Magil AB, Harris M, Scarth BJ, Gadawski I, Wang N, et al. Exploring mitochondrial nephrotoxicity as a potential mechanism of kidney dysfunction among HIV-infected patients on highly active antiretroviral therapy. Antivir Ther. 2006;11:79–86.PubMed Côté HCF, Magil AB, Harris M, Scarth BJ, Gadawski I, Wang N, et al. Exploring mitochondrial nephrotoxicity as a potential mechanism of kidney dysfunction among HIV-infected patients on highly active antiretroviral therapy. Antivir Ther. 2006;11:79–86.PubMed
20.
Zurück zum Zitat Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982–92.PubMedCrossRef Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982–92.PubMedCrossRef
21.
Zurück zum Zitat Bash LD, Coresh J, Kottgen A, Parekh RS, Fulop T, Wang Y, Astor BC. Defining incident chronic kidney disease in the research setting: the ARIC study. Am J Epidemiol. 2009;170:414–24.PubMedCrossRef Bash LD, Coresh J, Kottgen A, Parekh RS, Fulop T, Wang Y, Astor BC. Defining incident chronic kidney disease in the research setting: the ARIC study. Am J Epidemiol. 2009;170:414–24.PubMedCrossRef
22.
Zurück zum Zitat Ando M, Iwamoto Y, Suda A, Tsuchiya K, Nihei H. New insights into the thrombopoietic status of patients on dialysis through the evaluation of megakaryocytopoiesis in bone marrow and of endogenous thrombopoietin levels. Blood. 2001;97:915–21.PubMedCrossRef Ando M, Iwamoto Y, Suda A, Tsuchiya K, Nihei H. New insights into the thrombopoietic status of patients on dialysis through the evaluation of megakaryocytopoiesis in bone marrow and of endogenous thrombopoietin levels. Blood. 2001;97:915–21.PubMedCrossRef
23.
Zurück zum Zitat Nakamura Y, Shibuya A, Suzuki H, Ando M. Prevalence of chronic kidney disease (CKD) and significant contributors to CKD in HIV-infected patients. Nippon Jinzo Gakkai Shi. 2008;50:499–505.PubMed Nakamura Y, Shibuya A, Suzuki H, Ando M. Prevalence of chronic kidney disease (CKD) and significant contributors to CKD in HIV-infected patients. Nippon Jinzo Gakkai Shi. 2008;50:499–505.PubMed
24.
Zurück zum Zitat Bang H, Vupputuri S, Shoham DA, Klemmer PJ, Falk RJ, Mazumdar M, et al. SCreening for Occult REnal Disease (SCORED): a simple prediction model for chronic kidney disease. Arch Intern Med. 2007;167:374–81.PubMedCrossRef Bang H, Vupputuri S, Shoham DA, Klemmer PJ, Falk RJ, Mazumdar M, et al. SCreening for Occult REnal Disease (SCORED): a simple prediction model for chronic kidney disease. Arch Intern Med. 2007;167:374–81.PubMedCrossRef
25.
Zurück zum Zitat Akobeng AK. Understanding diagnostic tests 3: receiver operating characteristic curves. Acta Paediatr. 2007;96:644–7.PubMedCrossRef Akobeng AK. Understanding diagnostic tests 3: receiver operating characteristic curves. Acta Paediatr. 2007;96:644–7.PubMedCrossRef
26.
Zurück zum Zitat Fischer JE, Bachmann LM, Jaeschke R. A readers’ guide to the interpretation of diagnostic test properties: clinical example of sepsis. Intensive Care Med. 2003;29:1043–51.PubMedCrossRef Fischer JE, Bachmann LM, Jaeschke R. A readers’ guide to the interpretation of diagnostic test properties: clinical example of sepsis. Intensive Care Med. 2003;29:1043–51.PubMedCrossRef
27.
Zurück zum Zitat Kshirsagar AV, Bang H, Bomback A, et al. A simple algorithm to predict incident kidney disease. Arch Intern Med. 2008;168:2466–73.PubMedCrossRef Kshirsagar AV, Bang H, Bomback A, et al. A simple algorithm to predict incident kidney disease. Arch Intern Med. 2008;168:2466–73.PubMedCrossRef
28.
Zurück zum Zitat Barraclough K, Er L, Ng F, Harris M, Montaner J, Levin A. A comparison of the predictive performance of different methods of kidney function estimation in a well-characterized HIV-infected population. Nephron Clin Pract. 2009;111:c39–48.PubMedCrossRef Barraclough K, Er L, Ng F, Harris M, Montaner J, Levin A. A comparison of the predictive performance of different methods of kidney function estimation in a well-characterized HIV-infected population. Nephron Clin Pract. 2009;111:c39–48.PubMedCrossRef
Metadaten
Titel
A simple model for predicting incidence of chronic kidney disease in HIV-infected patients
verfasst von
Minoru Ando
Naoki Yanagisawa
Atsushi Ajisawa
Ken Tsuchiya
Kosaku Nitta
Publikationsdatum
01.04.2011
Verlag
Springer Japan
Erschienen in
Clinical and Experimental Nephrology / Ausgabe 2/2011
Print ISSN: 1342-1751
Elektronische ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-010-0393-x

Weitere Artikel der Ausgabe 2/2011

Clinical and Experimental Nephrology 2/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.